Research Papers:

Genetic variant in visfatin gene promoter contributes to reduced risk of hepatocellular carcinoma in a Chinese population

Zhitong Wu, Yifan Sun _, Yiyong Huang, Shengbo Zhu, Yi Feng, Huifen Ye, Chunming Liu and Shifu Tang

PDF  |  HTML  |  How to cite

Oncotarget. 2016; 7:77968-77977. https://doi.org/10.18632/oncotarget.12864

Metrics: PDF 1306 views  |   HTML 1608 views  |   ?  


Zhitong Wu1,*, Yifan Sun2,*, Yiyong Huang2, Shengbo Zhu2, Yi Feng1, Huifen Ye1, Chunming Liu2, Shifu Tang2

1Department of Clinical Laboratory, Eighth Affiliated Hospital of Guangxi Medical University, Guigang City People’s Hospital, Guigang, Guangxi, China

2Department of Clinical Laboratory, Third Affiliated Hospital of Guangxi University of Chinese Medicine, Liuzhou, Guangxi, China

*These authors have contributed equally to the article, so they should be considered as the co-first authors

Correspondence to:

Yifan Sun, email: [email protected]

Keywords: visfatin, polymorphism, hepatocellular carcinoma

Received: September 07, 2016     Accepted: October 12, 2016     Published: October 25, 2016


Knowledge on the role of gene variants in the visfatin promoter region in the hepatitis B virus (HBV)-related liver diseases is limited. In this study, we genotyped two potentially functional single nucleotide polymorphisms (SNPs) in the visfatin promoter region, -1535C>T (rs61330082) and -3187G>A (rs11977021), in 120 HBV-related chronic hepatitis B (CHB) patients, 140 HBV-related liver cirrhosis (HBV-LC) patients, 243 HBV-related hepatocellular carcinoma (HBV-HCC) patients, and 224 asymptomatic HBV carriers. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated by logistic regression. The results showed subjects with a TT genotype of -1535C>T had a significantly decreased risk of HBV-HCC related to the CC and CC + CT genotypes (adjusted OR = 0.493, 95% CI = 0.313-0.778; OR = 0.535, 95% CI = 0.362-0.791, respectively). A lowered risk also appeared in the comparison between allele T and allele C (OR = 0.734, 95%, CI = 0.581-0.950). However, these associations existed only in people with Zhuang ethnicity, but not in people with Han ethnicity. There were no significant associations between -3187G>A polymorphisms and the risk of HBV-related liver diseases. Our results suggested that visfatin -1535C>T polymorphisms might be associated with decreased risk of HBV-HCC among the ethnic Zhuang population in Guangxi, China.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 12864